ArticleGenes2015

Hypermethylation of the VTRNA1-3 Promoter is Associated with Poor Outcome in Lower Risk Myelodysplastic Syndrome Patients.

Alexandra Søgaard Helbo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.